25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CPHI (China Pharma Holdings Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze China Pharma Holdings Inc together

I guess you are interested in China Pharma Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – China Pharma Holdings Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – China Pharma Holdings Inc’s Price Targets

I'm going to help you getting a better view of China Pharma Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about China Pharma Holdings Inc

I send you an email if I find something interesting about China Pharma Holdings Inc.

1. Quick Overview

1.1. Quick analysis of China Pharma Holdings Inc (30 sec.)










1.2. What can you expect buying and holding a share of China Pharma Holdings Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.39
Expected worth in 1 year
$1.04
How sure are you?
10.0%

+ What do you gain per year?

Total Gains per Share
$0.66
Return On Investment
43.9%

For what price can you sell your share?

Current Price per Share
$1.50
Expected price per share
$0.688 - $1.8851145548466
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of China Pharma Holdings Inc (5 min.)




Live pricePrice per Share (EOD)
$1.50
Intrinsic Value Per Share
$-1.02 - $0.30
Total Value Per Share
$-0.63 - $0.68

2.2. Growth of China Pharma Holdings Inc (5 min.)




Is China Pharma Holdings Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$7.4m$4.2m$3.1m42.5%

How much money is China Pharma Holdings Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3m-$10.2m$7.1m232.0%
Net Profit Margin-43.9%-126.1%--

How much money comes from the company's main activities?

2.3. Financial Health of China Pharma Holdings Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of China Pharma Holdings Inc?

Welcome investor! China Pharma Holdings Inc's management wants to use your money to grow the business. In return you get a share of China Pharma Holdings Inc.

First you should know what it really means to hold a share of China Pharma Holdings Inc. And how you can make/lose money.

Speculation

The Price per Share of China Pharma Holdings Inc is $1.4966. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of China Pharma Holdings Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in China Pharma Holdings Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.39. Based on the TTM, the Book Value Change Per Share is $0.16 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of China Pharma Holdings Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.16-10.7%-0.16-10.7%-0.53-35.5%-0.42-28.0%-0.70-46.7%
Usd Book Value Change Per Share0.1611.0%0.1611.0%-0.09-6.0%-0.24-15.8%-0.65-43.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.1611.0%0.1611.0%-0.09-6.0%-0.24-15.8%-0.65-43.6%
Usd Price Per Share0.12-0.12-0.10-0.28-0.25-
Price to Earnings Ratio-0.76--0.76--0.18--1.38--0.84-
Price-to-Total Gains Ratio0.74-0.74--1.07--2.44--1.35-
Price to Book Ratio0.31-0.31-0.43-0.77-0.43-
Price-to-Total Gains Ratio0.74-0.74--1.07--2.44--1.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.4966
Number of shares668
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.16-0.24
Usd Total Gains Per Share0.16-0.24
Gains per Quarter (668 shares)109.80-157.82
Gains per Year (668 shares)439.19-631.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104394290-631-641
208788680-1263-1272
30131813070-1894-1903
40175717460-2525-2534
50219621850-3156-3165
60263526240-3788-3796
70307430630-4419-4427
80351435020-5050-5058
90395339410-5682-5689
100439243800-6313-6320

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%8.015.00.034.8%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%9.012.02.039.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%1.00.022.04.3%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%10.012.01.043.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of China Pharma Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1640.1640%-0.090+155%-0.236+244%-0.652+497%
Book Value Per Share--0.3870.3870%0.223+74%0.364+6%1.797-78%
Current Ratio--0.8790.8790%0.468+88%0.647+36%1.292-32%
Debt To Asset Ratio--0.5470.5470%0.759-28%0.649-16%0.456+20%
Debt To Equity Ratio--1.2091.2090%3.145-62%2.033-41%1.197+1%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value---5261079.600-5261079.6000%-9617772.940+83%-5659213.372+8%-9080772.486+73%
Eps---0.160-0.1600%-0.531+232%-0.418+162%-0.698+337%
Ev To Ebitda Ratio---623.646-623.6460%11.481-5532%-127.875-79%-60.455-90%
Ev To Sales Ratio---0.750-0.7500%-1.187+58%-0.639-15%-0.698-7%
Free Cash Flow Per Share---0.037-0.0370%-0.042+14%-0.028-26%0.009-512%
Free Cash Flow To Equity Per Share---0.033-0.0330%-0.134+305%-0.009-73%-0.059+78%
Gross Profit Margin--1.2531.2530%1.105+13%1.310-4%1.288-3%
Intrinsic Value_10Y_max--0.297--------
Intrinsic Value_10Y_min---1.018--------
Intrinsic Value_1Y_max--0.013--------
Intrinsic Value_1Y_min---0.055--------
Intrinsic Value_3Y_max--0.053--------
Intrinsic Value_3Y_min---0.207--------
Intrinsic Value_5Y_max--0.107--------
Intrinsic Value_5Y_min---0.403--------
Market Cap28814638.440+92%2329661.4002329661.4000%1846401.060+26%5322024.828-56%4875153.414-52%
Net Profit Margin---0.439-0.4390%-1.261+187%-0.865+97%-0.918+109%
Operating Margin---0.392-0.3920%-0.437+12%-0.283-28%-0.349-11%
Operating Ratio--1.3921.3920%1.450-4%1.340+4%0.497+180%
Pb Ratio3.865+92%0.3130.3130%0.430-27%0.771-59%0.428-27%
Pe Ratio-9.359-1137%-0.757-0.7570%-0.181-76%-1.377+82%-0.841+11%
Price Per Share1.497+92%0.1210.1210%0.096+26%0.276-56%0.253-52%
Price To Free Cash Flow Ratio-40.515-1137%-3.276-3.2760%-2.275-31%-3.768+15%-0.970-70%
Price To Total Gains Ratio9.105+92%0.7360.7360%-1.069+245%-2.438+431%-1.346+283%
Quick Ratio--0.3160.3160%0.197+60%0.277+14%0.596-47%
Return On Assets---0.187-0.1870%-0.575+207%-0.406+117%-0.306+64%
Return On Equity---0.413-0.4130%-2.383+477%-1.224+196%-0.754+83%
Total Gains Per Share--0.1640.1640%-0.090+155%-0.236+244%-0.652+497%
Usd Book Value--7454621.0007454621.0000%4289998.000+74%7000926.400+6%34607883.700-78%
Usd Book Value Change Per Share--0.1640.1640%-0.090+155%-0.236+244%-0.652+497%
Usd Book Value Per Share--0.3870.3870%0.223+74%0.364+6%1.797-78%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value---5261079.600-5261079.6000%-9617772.940+83%-5659213.372+8%-9080772.486+73%
Usd Eps---0.160-0.1600%-0.531+232%-0.418+162%-0.698+337%
Usd Free Cash Flow---711203.000-711203.0000%-811509.000+14%-529572.600-26%172466.200-512%
Usd Free Cash Flow Per Share---0.037-0.0370%-0.042+14%-0.028-26%0.009-512%
Usd Free Cash Flow To Equity Per Share---0.033-0.0330%-0.134+305%-0.009-73%-0.059+78%
Usd Market Cap28814638.440+92%2329661.4002329661.4000%1846401.060+26%5322024.828-56%4875153.414-52%
Usd Price Per Share1.497+92%0.1210.1210%0.096+26%0.276-56%0.253-52%
Usd Profit---3078818.000-3078818.0000%-10221635.000+232%-8285325.600+169%-12208987.700+297%
Usd Revenue--7011299.0007011299.0000%8104092.000-13%9309540.200-25%13014671.200-46%
Usd Total Gains Per Share--0.1640.1640%-0.090+155%-0.236+244%-0.652+497%
 EOD+6 -2MRQTTM+0 -0YOY+35 -35Y+22 -1610Y+18 -20

3.3 Fundamental Score

Let's check the fundamental score of China Pharma Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.359
Price to Book Ratio (EOD)Between0-13.865
Net Profit Margin (MRQ)Greater than0-0.439
Operating Margin (MRQ)Greater than0-0.392
Quick Ratio (MRQ)Greater than10.316
Current Ratio (MRQ)Greater than10.879
Debt to Asset Ratio (MRQ)Less than10.547
Debt to Equity Ratio (MRQ)Less than11.209
Return on Equity (MRQ)Greater than0.15-0.413
Return on Assets (MRQ)Greater than0.05-0.187
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of China Pharma Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5087.834
Ma 20Greater thanMa 500.407
Ma 50Greater thanMa 1000.300
Ma 100Greater thanMa 2000.252
OpenGreater thanClose1.590
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About China Pharma Holdings Inc

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.

Fundamental data was last updated by Penke on 2025-03-29 23:52:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ China Pharma Holdings Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ China Pharma Holdings Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -43.9%Β means thatΒ $-0.44 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of China Pharma Holdings Inc:

  • The MRQ is -43.9%. The company is making a huge loss. -2
  • The TTM is -43.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-43.9%TTM-43.9%0.0%
TTM-43.9%YOY-126.1%+82.2%
TTM-43.9%5Y-86.5%+42.6%
5Y-86.5%10Y-91.8%+5.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ China Pharma Holdings Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ China Pharma Holdings Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -18.7% Return on Assets means thatΒ China Pharma Holdings Inc generatedΒ $-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of China Pharma Holdings Inc:

  • The MRQ is -18.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.7%TTM-18.7%0.0%
TTM-18.7%YOY-57.5%+38.8%
TTM-18.7%5Y-40.6%+21.9%
5Y-40.6%10Y-30.6%-10.0%
4.3.1.3. Return on Equity

Shows how efficient China Pharma Holdings Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ China Pharma Holdings Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -41.3% Return on Equity means China Pharma Holdings Inc generated $-0.41Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of China Pharma Holdings Inc:

  • The MRQ is -41.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -41.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.3%TTM-41.3%0.0%
TTM-41.3%YOY-238.3%+197.0%
TTM-41.3%5Y-122.4%+81.1%
5Y-122.4%10Y-75.4%-47.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of China Pharma Holdings Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient China Pharma Holdings Inc is operatingΒ .

  • Measures how much profit China Pharma Holdings Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ China Pharma Holdings Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -39.2%Β means the company generated $-0.39 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of China Pharma Holdings Inc:

  • The MRQ is -39.2%. The company is operating very inefficient. -2
  • The TTM is -39.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-39.2%TTM-39.2%0.0%
TTM-39.2%YOY-43.7%+4.5%
TTM-39.2%5Y-28.3%-10.8%
5Y-28.3%10Y-34.9%+6.6%
4.3.2.2. Operating Ratio

Measures how efficient China Pharma Holdings Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.39 means that the operating costs are $1.39 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of China Pharma Holdings Inc:

  • The MRQ is 1.392. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.392. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.392TTM1.3920.000
TTM1.392YOY1.450-0.057
TTM1.3925Y1.340+0.052
5Y1.34010Y0.497+0.843
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of China Pharma Holdings Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if China Pharma Holdings Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.88Β means the company has $0.88 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of China Pharma Holdings Inc:

  • The MRQ is 0.879. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.879. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.879TTM0.8790.000
TTM0.879YOY0.468+0.411
TTM0.8795Y0.647+0.232
5Y0.64710Y1.292-0.645
4.4.3.2. Quick Ratio

Measures if China Pharma Holdings Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ China Pharma Holdings Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.32Β means the company can pay off $0.32 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of China Pharma Holdings Inc:

  • The MRQ is 0.316. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.316. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.316TTM0.3160.000
TTM0.316YOY0.197+0.119
TTM0.3165Y0.277+0.038
5Y0.27710Y0.596-0.318
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of China Pharma Holdings Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of China Pharma Holdings IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ China Pharma Holdings Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.55Β means that China Pharma Holdings Inc assets areΒ financed with 54.7% credit (debt) and the remaining percentage (100% - 54.7%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of China Pharma Holdings Inc:

  • The MRQ is 0.547. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.547. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.547TTM0.5470.000
TTM0.547YOY0.759-0.211
TTM0.5475Y0.649-0.102
5Y0.64910Y0.456+0.193
4.5.4.2. Debt to Equity Ratio

Measures ifΒ China Pharma Holdings Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ China Pharma Holdings Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 120.9% means that company has $1.21 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of China Pharma Holdings Inc:

  • The MRQ is 1.209. The company is able to pay all its debts with equity. +1
  • The TTM is 1.209. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.209TTM1.2090.000
TTM1.209YOY3.145-1.936
TTM1.2095Y2.033-0.823
5Y2.03310Y1.197+0.835
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings China Pharma Holdings Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ China Pharma Holdings Inc to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -0.76 means the investor is paying $-0.76Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of China Pharma Holdings Inc:

  • The EOD is -9.359. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.757. Based on the earnings, the company is expensive. -2
  • The TTM is -0.757. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.359MRQ-0.757-8.602
MRQ-0.757TTM-0.7570.000
TTM-0.757YOY-0.181-0.576
TTM-0.7575Y-1.377+0.620
5Y-1.37710Y-0.841-0.536
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of China Pharma Holdings Inc:

  • The EOD is -40.515. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.276. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.276. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-40.515MRQ-3.276-37.240
MRQ-3.276TTM-3.2760.000
TTM-3.276YOY-2.275-1.000
TTM-3.2765Y-3.768+0.493
5Y-3.76810Y-0.970-2.799
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ China Pharma Holdings Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.31 means the investor is paying $0.31Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of China Pharma Holdings Inc:

  • The EOD is 3.865. Based on the equity, the company is fair priced.
  • The MRQ is 0.313. Based on the equity, the company is cheap. +2
  • The TTM is 0.313. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.865MRQ0.313+3.553
MRQ0.313TTM0.3130.000
TTM0.313YOY0.430-0.118
TTM0.3135Y0.771-0.458
5Y0.77110Y0.428+0.343
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of China Pharma Holdings Inc.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income Tax Expense  322-282942485425,7076,249-6,2490



5.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets16,469
Total Liabilities9,015
Total Stockholder Equity7,455
 As reported
Total Liabilities 9,015
Total Stockholder Equity+ 7,455
Total Assets = 16,469

Assets

Total Assets16,469
Total Current Assets5,997
Long-term Assets10,472
Total Current Assets
Cash And Cash Equivalents 1,424
Short-term Investments 66
Net Receivables 662
Inventory 3,733
Other Current Assets 178
Total Current Assets  (as reported)5,997
Total Current Assets  (calculated)6,063
+/- 66
Long-term Assets
Property Plant Equipment 6,819
Goodwill 398
Intangible Assets 3,653
Long-term Assets Other -398
Long-term Assets  (as reported)10,472
Long-term Assets  (calculated)10,472
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,821
Long-term Liabilities2,194
Total Stockholder Equity7,455
Total Current Liabilities
Short-term Debt 3,182
Short Long Term Debt 3,104
Accounts payable 966
Other Current Liabilities 1,554
Total Current Liabilities  (as reported)6,821
Total Current Liabilities  (calculated)8,807
+/- 1,987
Long-term Liabilities
Long term Debt 1,412
Capital Lease Obligations 118
Long-term Liabilities  (as reported)2,194
Long-term Liabilities  (calculated)1,530
+/- 664
Total Stockholder Equity
Common Stock11
Retained Earnings -39,290
Accumulated Other Comprehensive Income 11,452
Other Stockholders Equity 35,282
Total Stockholder Equity (as reported)7,455
Total Stockholder Equity (calculated)7,455
+/-0
Other
Capital Stock11
Cash and Short Term Investments 1,424
Common Stock Shares Outstanding 3,384
Current Deferred Revenue91
Liabilities and Stockholders Equity 16,469
Net Debt 3,210
Net Invested Capital 11,971
Net Working Capital -824
Property Plant and Equipment Gross 37,214
Short Long Term Debt Total 4,634



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
> Total Assets 
426
426
299
0
0
28,514
43,706
75,472
100,941
131,751
156,391
163,240
157,611
132,082
97,222
78,520
59,953
45,377
22,235
21,118
22,650
17,784
16,469
16,46917,78422,65021,11822,23545,37759,95378,52097,222132,082157,611163,240156,391131,751100,94175,47243,70628,51400299426426
   > Total Current Assets 
4
4
4
0
0
25,707
38,830
59,732
71,303
91,934
110,609
112,531
83,956
54,493
24,957
17,520
12,290
8,747
5,579
5,322
9,093
5,965
5,997
5,9975,9659,0935,3225,5798,74712,29017,52024,95754,49383,956112,531110,60991,93471,30359,73238,83025,70700444
       Cash And Cash Equivalents 
1
1
2
0
0
656
1,830
6,927
3,635
3,692
4,051
4,030
5,993
5,296
6,249
2,666
2,030
1,187
1,075
958
4,859
2,030
1,424
1,4242,0304,8599581,0751,1872,0302,6666,2495,2965,9934,0304,0513,6923,6356,9271,83065600211
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
84
102
336
458
0
0
40
21
46
54
91
14
66
6614915446214000458336102840000000000
       Net Receivables 
3
3
2
0
6,096
12,458
19,069
36,172
53,115
62,013
69,751
66,358
45,659
25,582
6,173
4,224
2,496
1,108
728
583
835
464
662
6624648355837281,1082,4964,2246,17325,58245,65966,35869,75162,01353,11536,17219,06912,4586,0960233
       Other Current Assets 
0
0
0
0
2,124
2,315
3,482
3,032
320
5,841
84
4,816
7,627
7,889
2,872
3,319
40
21
187
76
59
522
178
178522597618721403,3192,8727,8897,6274,816845,8413203,0323,4822,3152,1240000
   > Long-term Assets 
422
422
295
0
3,035
2,807
4,876
15,740
29,638
39,817
45,782
50,709
73,655
77,589
72,265
61,000
47,663
36,630
16,656
15,796
13,556
11,820
10,472
10,47211,82013,55615,79616,65636,63047,66361,00072,26577,58973,65550,70945,78239,81729,63815,7404,8762,8073,0350295422422
       Property Plant Equipment 
422
422
295
0
2,808
2,725
2,625
6,738
6,706
6,372
6,335
8,585
29,780
33,423
28,959
24,562
23,108
18,885
16,047
15,182
12,967
9,608
6,819
6,8199,60812,96715,18216,04718,88523,10824,56228,95933,42329,7808,5856,3356,3726,7066,7382,6252,7252,8080295422422
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
398
3980000000000000000000000
       Intangible Assets 
0
0
0
0
96
65
2,063
6,163
22,932
29,049
3,083
2,860
2,173
1,776
1,275
940
832
676
609
614
590
2,212
3,653
3,6532,2125906146096768329401,2751,7762,1732,8603,08329,04922,9326,1632,06365960000
       Other Assets 
0
0
0
0
0
0
188
2,839
3,600
4,396
36,364
39,264
41,702
42,390
42,031
35,498
23,723
17,070
0
50
0
0
0
00050017,07023,72335,49842,03142,39041,70239,26436,3644,3963,6002,839188000000
> Total Liabilities 
992
992
1,033
68
68
7,664
3,945
5,604
10,545
13,814
13,908
14,723
24,667
25,828
24,581
19,611
16,882
15,179
12,998
13,113
16,632
13,494
9,015
9,01513,49416,63213,11312,99815,17916,88219,61124,58125,82824,66714,72313,90813,81410,5455,6043,9457,66468681,033992992
   > Total Current Liabilities 
673
673
906
68
68
7,632
3,911
5,567
10,508
12,808
13,779
14,627
12,006
14,172
12,791
10,398
9,227
10,051
10,045
11,404
10,513
12,739
6,821
6,82112,73910,51311,40410,04510,0519,22710,39812,79114,17212,00614,62713,77912,80810,5085,5673,9117,6326868906673673
       Short-term Debt 
444
444
639
0
0
6,534
2,693
2,480
3,803
3,781
3,932
4,761
4,910
6,516
6,163
2,529
3,015
3,455
2,351
6,524
7,194
8,757
3,182
3,1828,7577,1946,5242,3513,4553,0152,5296,1636,5164,9104,7613,9323,7813,8032,4802,6936,53400639444444
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
18,748
1,629
1,541
2,529
3,015
3,455
2,260
6,472
7,109
8,717
3,104
3,1048,7177,1096,4722,2603,4553,0152,5291,5411,62918,748000000000000
       Accounts payable 
200
200
190
68
68
500
297
1,049
3,958
4,938
3,112
2,842
1,877
2,551
2,825
3,060
1,141
1,061
1,366
1,235
927
667
966
9666679271,2351,3661,0611,1413,0602,8252,5511,8772,8423,1124,9383,9581,0492975006868190200200
       Other Current Liabilities 
30
0
77
4
5,092
327
348
-691,140
-1,034,945
-1,208,983,911
4,950
5,078
2,991
3,026
3,208
3,997
4,490
5,010
5,822
2,926
1,341
1,729
1,554
1,5541,7291,3412,9265,8225,0104,4903,9973,2083,0262,9915,0784,950-1,208,983,911-1,034,945-691,1403483275,092477030
   > Long-term Liabilities 
319
319
127
68
68
32
34
36
37
1,006
129
96
12,661
11,656
11,790
9,213
7,654
5,127
2,952
1,710
6,119
755
2,194
2,1947556,1191,7102,9525,1277,6549,21311,79011,65612,661961291,006373634326868127319319
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
12,484
1,629
1,541
1,440
6,916
4,363
2,150
0
0
0
0
00002,1504,3636,9161,4401,5411,62912,484000000000000
       Other Liabilities 
0
0
0
0
0
0
34
37
37
934
0
0
176
2,516
297
572
738
764
753
806
824
0
0
008248067537647385722972,51617600934373734000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
129
0
176
2,516
708
572
738
764
753
806
0
0
0
0008067537647385727082,51617601290000000000
> Total Stockholder Equity
-566
-566
-734
-68
-68
20,850
39,761
69,868
90,396
117,937
142,483
148,517
132,944
106,254
72,641
58,909
43,071
30,199
9,238
8,005
6,018
4,290
7,455
7,4554,2906,0188,0059,23830,19943,07158,90972,641106,254132,944148,517142,483117,93790,39669,86839,76120,850-68-68-734-566-566
   Common Stock
7
7
0
1
1
35
37
42
42
43
44
44
44
44
44
44
44
44
44
46
47
75
11
11754746444444444444444444434242373511077
   Retained Earnings 
-2,809
-2,809
-3,035
-3,834
-3,834
12,387
25,206
43,040
63,273
85,017
104,287
108,904
88,896
62,849
33,940
24,757
5,480
-5,270
-25,972
-28,839
-32,239
-36,211
-39,290
-39,290-36,211-32,239-28,839-25,972-5,2705,48024,75733,94062,84988,896108,904104,28785,01763,27343,04025,20612,387-3,834-3,834-3,035-2,809-2,809
   Accumulated Other Comprehensive Income 
-204
3
7
2
2
664
2,839
5,720
5,903
9,624
14,704
15,978
20,414
19,771
15,067
10,518
13,958
11,835
11,576
12,345
12,564
11,573
11,452
11,45211,57312,56412,34511,57611,83513,95810,51815,06719,77120,41415,97814,7049,6245,9035,7202,8396642273-204
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
23,449
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
24,453
0
0
0
00024,45323,59023,59023,59023,59023,59023,59023,59023,59023,4490000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
2,439
2,232
2,294
3,763
3,763
7,765
11,679
21,066
21,178
23,252
23,449
23,590
23,590
23,590
23,590
23,590
23,590
23,590
23,590
24,453
25,645
28,854
35,282
35,28228,85425,64524,45323,59023,59023,59023,59023,59023,59023,59023,59023,44923,25221,17821,06611,6797,7653,7633,7632,2942,2322,439



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,011
Cost of Revenue-7,292
Gross Profit-281-281
 
Operating Income (+$)
Gross Profit-281
Operating Expense-2,471
Operating Income-2,752-2,752
 
Operating Expense (+$)
Research Development240
Selling General Administrative1,466
Selling And Marketing Expenses780
Operating Expense2,4712,486
 
Net Interest Income (+$)
Interest Income5
Interest Expense-334
Other Finance Cost-46
Net Interest Income-374
 
Pretax Income (+$)
Operating Income-2,752
Net Interest Income-374
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,079-2,425
EBIT - interestExpense = -3,079
-3,079
-2,745
Interest Expense334
Earnings Before Interest and Taxes (EBIT)-2,745-2,745
Earnings Before Interest and Taxes (EBITDA)8
 
After tax Income (+$)
Income Before Tax-3,079
Tax Provision-0
Net Income From Continuing Ops-3,111-3,079
Net Income-3,079
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses9,763
Total Other Income/Expenses Net-327374
 

Technical Analysis of China Pharma Holdings Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of China Pharma Holdings Inc. The general trend of China Pharma Holdings Inc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine China Pharma Holdings Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. China Pharma Holdings Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of China Pharma Holdings Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.66 < 1.772 < 1.8851145548466.

The bearish price targets are: 1.212 > 1.1575 > 0.688.

Know someone who trades $CPHI? Share this with them.πŸ‘‡

China Pharma Holdings Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of China Pharma Holdings Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

China Pharma Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of China Pharma Holdings Inc. The current macd is 0.22891717.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the China Pharma Holdings Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for China Pharma Holdings Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the China Pharma Holdings Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
China Pharma Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartChina Pharma Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of China Pharma Holdings Inc. The current adx is 45.13.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy China Pharma Holdings Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
China Pharma Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of China Pharma Holdings Inc. The current sar is 0.1685.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
China Pharma Holdings Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of China Pharma Holdings Inc. The current rsi is 87.83. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending down: The RSI is trending down. -1
China Pharma Holdings Inc Daily Relative Strength Index (RSI) ChartChina Pharma Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of China Pharma Holdings Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the China Pharma Holdings Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
China Pharma Holdings Inc Daily Stochastic Oscillator ChartChina Pharma Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of China Pharma Holdings Inc. The current cci is 234.58.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
China Pharma Holdings Inc Daily Commodity Channel Index (CCI) ChartChina Pharma Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of China Pharma Holdings Inc. The current cmo is 79.73.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
China Pharma Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartChina Pharma Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of China Pharma Holdings Inc. The current willr is -22.66292135.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that China Pharma Holdings Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
China Pharma Holdings Inc Daily Williams %R ChartChina Pharma Holdings Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of China Pharma Holdings Inc.

China Pharma Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of China Pharma Holdings Inc. The current atr is 0.17962075.

China Pharma Holdings Inc Daily Average True Range (ATR) ChartChina Pharma Holdings Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of China Pharma Holdings Inc. The current obv is 49,044,519.

China Pharma Holdings Inc Daily On-Balance Volume (OBV) ChartChina Pharma Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of China Pharma Holdings Inc. The current mfi is 69.84.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
China Pharma Holdings Inc Daily Money Flow Index (MFI) ChartChina Pharma Holdings Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for China Pharma Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-17STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

China Pharma Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of China Pharma Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5087.834
Ma 20Greater thanMa 500.407
Ma 50Greater thanMa 1000.300
Ma 100Greater thanMa 2000.252
OpenGreater thanClose1.590
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of China Pharma Holdings Inc with someone you think should read this too:
  • Are you bullish or bearish on China Pharma Holdings Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about China Pharma Holdings Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about China Pharma Holdings Inc

I send you an email if I find something interesting about China Pharma Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about China Pharma Holdings Inc.

Receive notifications about China Pharma Holdings Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.